investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy

Naoto Hirano

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

William Muller

Assess the relative contribution of particular signaling molecules to each stage of breast cancer progression (CANADA RESEARCH CHAIRHOLDER)

All cancers but non-melanoma skin cancer

Federico Bernal

Broadening the Utility of Stapled Peptides through Chemical Optimization

All cancers but non-melanoma skin cancer

Radiation Oncology

Sankar Mitra

Repair Co-ordination of Radiation-Induced Clustered Damage In Mammalian Genomes

All cancers but non-melanoma skin cancer

Radiation Oncology

Philippe Roux

Signalling pathways important for cancer cell growth and proliferation (CANADA RESEARCH CHAIRHOLDER)

All cancers but non-melanoma skin cancer

Francois Bachand

CRC Tier 2 - RNA synthesis

All cancers but non-melanoma skin cancer

Jeffrey Wrana

qTAP, A Novel Platform for Personalized Medicine in Cancer

All cancers but non-melanoma skin cancer

Stefan Taubert

CRC Tier 2 - Studying Mediator Components

All cancers but non-melanoma skin cancer

Alba Guarne

Understanding the mechanisms that regulate DNA replication

All cancers but non-melanoma skin cancer

Charles Vinson

Gene Regulation and Function: The B-ZIP Proteins

All cancers but non-melanoma skin cancer